Physician profile
Michael David Casey
NPI 1356397103
$13,306.69
in general payments reported to CMS, 2019-2025
59 companies · $2,097 in 2025
The $2,097 reported for 2025 was more than what 96% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,538 · 2020: $1,374 · 2021: $2,425 · 2022: $1,730 · 2023: $2,012 · 2024: $2,129 · 2025: $2,097.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,173 · Education: $64.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,173.22 |
| Education | $64.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,956.77 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Novo Nordisk INC | $1,541.37 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals Lp | $1,216.72 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Pfizer INC. | $1,005.24 | 2019-2025 | |
| Abbvie INC. | $793.54 | 2021-2025 | Vraylar, Qulipta, Viberzi |
| Lilly USA, LLC | $716.02 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $523.10 | 2019-2025 | Xifaxan, Trulance |
| Amgen INC. | $410.80 | 2019-2025 | Evenity, Prolia, Prolia |
| Merck Sharp & Dohme LLC | $408.97 | 2019-2025 | Gardasil 9, Capvaxive, Vaxneuvance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $405.39 | 2019-2025 | Ofev, Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $379.13 | 2022-2025 | |
| Ironwood Pharmaceuticals, INC | $369.24 | 2020-2024 | Linzess |
| Astellas Pharma US INC | $357.66 | 2019-2025 | Veozah, Myrbetriq |
| Dexcom, INC. | $268.27 | 2021-2025 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $264.47 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
Show all 59 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Casey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.